Key facts
- Japanese private equity firms are increasing their focus on Asian markets.
- Advantage Partners has been a key player in this expansion, launching Asia Funds and making multiple investments.
- The firm's Asia strategy, 'Japan Link,' aims to connect Japan and Asia for value creation.
- Recent investments include companies in healthcare, manufacturing, and technology sectors.
- Advantage Partners has also been active in raising significant capital for various funds, including its Japan Buyout Fund VIII and Asia Fund II.
Japanese private equity firms are increasingly looking beyond their domestic market to tap into the economic growth and expansion opportunities present in Asia. Traditionally focused on Japan, these firms are now establishing a stronger presence in countries like Singapore and India, seeking new suppliers and markets.
Advantage Partners, a significant player in the Japanese private equity landscape, is at the forefront of this regional expansion. The firm began its Asian operations in 2007 with a Hong Kong office to support its Japanese investee companies. Over the subsequent decade, it achieved success in helping portfolio companies grow in Asia and in sourcing and executing investments in China and North America, leading to successful exits.
In 2016, Advantage Partners launched its first Asia Fund, specifically targeting investment opportunities in greater China and developed Southeast Asian economies. This fund operates under the theme of 'Japan Link,' aiming to generate investment returns by fostering connections between Japan and Asia. The firm applies its established practices of hands-on management support and value enhancement to its portfolio companies in the region.
Recent news indicates continued activity and fundraising success for Advantage Partners. In May 2026, the firm raised $424 million for its Asia Fund II and closed its Japan Buyout Fund VIII at a ¥300 billion hard cap. The firm has also been strengthening its investment strategy teams, appointing new heads for real estate and renewables/sustainability.
Advantage Partners' Asia Fund has made notable investments, including ITS Science & Medical Pte Ltd in the healthcare sector (August 2025), Maeden Innovation Co., Ltd. in manufacturing (May 2023), Winsome Green in consumables/retail/distribution/manufacturing (September 2021), and Novare Technologies, Inc. in technology/IT services (January 2021). These investments highlight the fund's focus on founder/owner succession and value creation within the Asian market.